Stock of the Week – Rocket Pharmaceuticals (RCKT)
Our Stock of the week is Rocket Pharmaceuticals Inc (RCKT). RCKT is a clinical-stage biopharmaceutical company. It is focused on developing gene therapies for rare and devastating pediatric diseases. The company's pipeline products include RP-A501 for Danaon Disease,...
Stock of the Week – CECO Environmental (CECO)
Our Stock of the Week is CECO Environmental (CECO). CECO is an industrial company serving the industrial air, water, and energy transition markets. CECO offers improved air and water quality, optimized emissions management, and increased energy efficiency for...
Stock of the Week – Sensus Healthcare, Inc (SRTS)
Our Stock of the week is Sensus Healthcare, Inc (SRTS). The company develops medical devices that provide non-invasive and affordable treatment of keloids, melanoma, and non-melanoma skin malignancies. Over more than ten years, it has developed and patented...
Stock of the Week – Replimune Group, Inc. (REPL)
Our Stock of the Week is Replimune Group, Inc. (REPL). REPL is a clinical-stage biotechnology company focused on treatments that activate the immune system to battle cancer. The company recently announced a collaboration agreement with Roche for programs dealing with...
Stock of the Week – Nio (NIO)
Our Stock of the Week is NIO, Inc. (NIO). NIO designs, manufactures, and sells electric vehicles in China. One of its key innovations is BaaS or Battery as a Service. This allows a buyer to purchase a car without the batteries, which cost about $10,000 and subscribe...
Stock of the Week – Eight Stocks
With the Fed interest rate decision this week, there is likely to be substantial volatility. Our plan is to use that volatility for entry and exits into some of our favorite names. We believe that this is a market that favors aggressive trading over building...
Weekend Reading For Traders (Dec 10-11)
Welcome to the latest edition of “Weekend Reading For Traders”. We kick things off with an article that helps pinpoint the crux of how (and why) the primary market narrative seemed to do a “180” this past week. From there, we highlight an article that discusses...
The “Best” Trading System Is The One You Can Execute Effectively
After several years of trading, active investors tend to narrow their approach to trading. Some folks are pure day traders that prefer to be back to a 100% cash position by the end of the day, others only trade options exclusively, many choose only to buy names that...
Stock of the Week – Catalyst Pharmaceuticals (CPRX)
Our Stock of the Week is Catalyst Pharmaceuticals (CPRX). This is a repeat from three weeks ago, but it remains one of the best charts in the market. CPRX is a commercial-stage biopharma focused on medicines for rare diseases. In July, the stock just sharply higher...
Market Predictions Are Hazardous To Your Portfolio. Do This Instead.
It’s that time of year when investors are starting to get bombarded by all sorts of predictions about what “the market” is going to do next year. On the one hand, several prognosticators are convinced that sustained inflationary pressures, a hawkish Fed, and a (very)...
Sponsored by
